Home Blood Pressure Control and Drug Prescription Patterns among Thai Hypertensives: A 1-Year Analysis of Telehealth Assisted Instrument in Home Blood Pressure Monitoring Nationwide Pilot Project
Table 1
Demographics and patient characteristics.
Clinical characteristic
All n = 1,177
Controlled γ home BP group at one year n = 671 (57.0)
Uncontrolled home BP group at one year n = 506 (43.0)
value
Age (year)
58.9 ± 12.3
59.3 ± 12.1
58.4 ± 12.6
0.236
Female
699 (59.4)
395 (58.9)
304 (60.1)
0.675
Diabetes
154 (13.1)
82 (12.2)
72 (14.2)
0.092
Dyslipidemia$
602 (51.1)
326 (48.6)
276 (54.5)
0.038
Follow-up at primary care hospital
959 (81.5)
544 (81.1)
415 (82.0)
0.680
Body mass index (kg/m2)
26.5 ± 4.9
26.3 ± 4.9
26.8 ± 4.9
0.102
Waist circumference (cm)
89.0 ± 10.3
88.4 ± 10.0
89.7 ± 10.6
0.030
Chronic kidney disease with eGFR < 60 mL/min/1.73 m2†
265 (22.5)
144 (21.4)
121 (23.9)
0.374
Hypertension status at baseline
(i) Clinic BP
Systolic BP (mmHg)
143.9 ± 18.1
139.0 ± 16.8
150.5 ± 17.6
<0.001
Diastolic BP (mmHg)
84.3 ± 11.9
81.8 ± 11.0
87.6 ± 12.3
<0.001
<140/90 mmHg
503 (42.7)
377 (56.1)
126 (24.9)
<0.001
(ii) Home BP
Systolic BP (mmHg)
134.4 ± 15.3
126.7 ± 11.1
144.5 ± 14.1
<0.001
Diastolic BP (mmHg)
80.1 ± 9.4
76.2 ± 7.3
85.2 ± 9.3
<0.001
<135/85 mmHg
609 (51.8)
547 (81.5)
62 (12.3)
<0.001
(iii) Number of antihypertensive medications
1.9 ± 1.0
1.9 ± 0.9
2.0 ± 1.0
0.004
Hypertension status at one year of follow-up
(i) Clinic BP
Systolic BP (mmHg)
141.1 ± 16.2
132.8 ± 14.6
150.3 ± 15.4
<0.001
Diastolic BP (mmHg)
83.1 ± 10.8
79.1 ± 9.9
87.0 ± 11.3
<0.001
<140/90 mmHg
624 (53.0)
524 (78.1
100 (19.8)
<0.001
(ii) Home BP
Systolic BP (mmHg)
132.6 ± 15.0
122.6 ± 7.6
144.8 ± 12.1
<0.001
Diastolic BP (mmHg)
79.1 ± 9.5
74.0 ± 6.1
84.9 ± 8.7
<0.001
(iii) Number of antihypertensive medications
1.9 ± 1.2
1.9 ± 1.5
2.1 ± 1.1
< 0.001
Values are presented as means ± SD, number (%). BP = blood pressure. γControlled home BP group: participants who had home BP data at one year of <135/85 mmHg. Uncontrolled home BP group: participants who had home BP data at one year of ≥135/85 mmHg. $Dyslipidemia was defined as the total blood cholesterol level greater than 200 mg/dL, or low-density lipoprotein cholesterol level greater than 130 mg/dL, or fasting triglycerides level greater than 150 mg/dL; or using lipid-lowering drugs. †Estimated glomerular filtration rate (eGFR) calculated by the Modification of Diet in Renal Disease (MDRD) study equation.
